Valmet Secures Fourth Tissue Machine Order from Yusen, Expanding China Footprint
Event summary
- Valmet has secured an order for three IntelliTissue 1600 tissue machines from Yusen Group, marking the fourth consecutive order from the Chinese customer.
- The new machines will be installed at Yusen's mills in Tai'an, Liaoning Province, and Chongxin, Gansu Province, China, with startup scheduled for late 2026/early 2027.
- The order expands Yusen's production capacity and supports its ambition to grow in the high-end tissue product segment within the Chinese domestic market.
- Each machine will have a width of 3,500 mm, a design speed of 1,650 m/min, and an annual production capacity of 30,000 tonnes.
The big picture
This order underscores Valmet's strong position as a leading supplier of tissue-making technology, particularly in the rapidly growing Chinese market. Yusen's consistent investment in Valmet's IntelliTissue platform highlights the value placed on energy efficiency and reliability in a competitive landscape. The deal also reflects the broader trend of Chinese manufacturers upgrading production capabilities to meet rising domestic demand for higher-quality consumer goods.
What we're watching
- Market Dynamics
- The continued expansion of Yusen's high-end tissue production suggests sustained demand for premium tissue products in China, potentially signaling a shift in consumer preferences away from lower-priced alternatives.
- Supplier Dependence
- Yusen's repeated reliance on Valmet for tissue machine supply creates a degree of dependence that could expose them to pricing pressures or supply chain disruptions if Valmet's capacity is constrained.
- Geopolitical Risk
- The concentration of Yusen's production in Liaoning and Gansu provinces exposes the company to regional economic and regulatory shifts within China, which could impact operational efficiency and market access.
Related topics